BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $320,802 | -23.4% | 13,340 | +1.7% | 0.00% | -100.0% |
| Q2 2023 | $418,704 | +1.2% | 13,112 | -3.0% | 0.00% | 0.0% |
| Q1 2023 | $413,557 | -25.6% | 13,521 | -5.1% | 0.00% | 0.0% |
| Q4 2022 | $555,826 | -0.9% | 14,242 | +20.7% | 0.00% | 0.0% |
| Q3 2022 | $561,000 | -2.9% | 11,799 | -20.8% | 0.00% | 0.0% |
| Q2 2022 | $578,000 | -29.8% | 14,889 | +2.9% | 0.00% | -50.0% |
| Q1 2022 | $823,000 | -27.7% | 14,471 | +1.4% | 0.00% | 0.0% |
| Q4 2021 | $1,139,000 | -32.9% | 14,272 | -26.9% | 0.00% | -50.0% |
| Q3 2021 | $1,697,000 | -23.3% | 19,519 | +14.1% | 0.00% | -20.0% |
| Q2 2021 | $2,213,000 | +113.0% | 17,106 | +31.6% | 0.01% | +150.0% |
| Q1 2021 | $1,039,000 | +44.9% | 12,998 | +47.9% | 0.00% | 0.0% |
| Q4 2020 | $717,000 | +217.3% | 8,786 | -4.2% | 0.00% | +100.0% |
| Q3 2020 | $226,000 | -10.7% | 9,175 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $253,000 | – | 9,025 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |